Wellinks

Wellinks is a virtual-led cardiopulmonary care management platform specializing in chronic obstructive pulmonary disease (COPD) and congestive heart failure (CHF) management. The company delivers an integrated care model combining remote patient monitoring, virtual pulmonary rehabilitation, personalized clinical coaching, and predictive analytics. Following its acquisition of Spire Health, Wellinks now operates the Spire360 predictive clinical support platform, which continuously monitors respiratory and cardiac metrics using proprietary wearable technology (Spire Tag) and cloud-based analytics. The platform captures 2,000–4,000 breaths per day with 20+ hours median daily wear and predicts clinical deterioration up to 10 days in advance, enabling proactive interventions. Wellinks serves healthcare payers, value-based care organizations, and individual patients, demonstrating significant clinical impact: 16 million COPD-related visit reductions, $30,000 hospitalization cost reduction per patient, and 4% average annual savings. The MySpire patient app and Spire Hub (cellular-connected data hub) provide passive, continuous monitoring without daily user input, supporting long-term adherence critical for chronic disease management.